Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision
Launched by QUEEN'S MEDICAL CENTER · Apr 22, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well self-swab testing for sexually transmitted infections (STIs) works for patients who are receiving medication abortion care through telemedicine. The study aims to make STI testing more accessible for those who may have difficulty getting tested otherwise. Specifically, it will explore how acceptable and easy it is for patients to use self-collected STI tests, how many patients choose to use this service compared to those who go to a clinic, and what the rates of positive STI results are for both groups. The trial will also track how quickly patients who test positive can receive treatment.
To participate in this study, you need to be a female patient at the Queen Medical Center Options Center clinic seeking a telemedicine medication abortion, be at least 14 years old, and be able to read and speak English. Participants will collect their own samples at home for testing gonorrhea, chlamydia, and trichomonas, then send them to a lab using prepaid postage. After sending in their samples, participants will complete a survey about their experience. If anyone tests positive for an STI, they will be quickly referred for treatment. It’s important to note that this trial is not yet recruiting participants.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients of the Queen Medical Center Options Center clinic seeking telemedicine medication abortion.
- • 2. Patients for whom, according to the CDC guidelines for STI Testing11, STI testing is indicated, or patients who desire STI screening
- • 3. Age 14 and over
- • 4. Can speak and read English
- • 5. Displays capacity for informed consent
- Exclusion Criteria:
- • 1. Home address that is not located in the state of Hawai'i
- • 2. Incarcerated
- • 3. Unwilling to perform vaginal swab collection
About Queen's Medical Center
Queen's Medical Center, located in Honolulu, Hawaii, is a leading academic medical institution renowned for its commitment to innovative healthcare and clinical research. As a prominent clinical trial sponsor, Queen's Medical Center is dedicated to advancing medical knowledge and improving patient outcomes through rigorous research protocols and collaboration with various stakeholders in the medical community. The center focuses on a wide range of therapeutic areas, ensuring that its clinical trials adhere to the highest ethical standards and regulatory guidelines. With a patient-centered approach, Queen's Medical Center strives to contribute significantly to the development of new therapies and healthcare solutions that enhance the well-being of the diverse populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported